Cargando…

Prognostic and Immunological Roles of Cell Cycle Regulator CDCA5 in Human Solid Tumors

BACKGROUND: There have been several studies evaluating the prognostic significance of cell division cycle associated 5 (CDCA5). However, few reports analyzed the correlation between CDCA5 and prognosis of diverse cancers based on large clinical data. We thus comprehensively analyzed CDCA5 expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Jing, Zhou, Xin, Wang, Xiaping, Zhang, Qing, Zhang, Lan, Wang, Tongshan, Zhu, Wei, Liu, Ping, Zhu, Mingxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698365/ https://www.ncbi.nlm.nih.gov/pubmed/36438022 http://dx.doi.org/10.2147/IJGM.S389275

Ejemplares similares

Prognostic value and immunological role of FOXM1 in human solid tumors
por: Wei, Guohua, et al.
Publicado: (2022)

Integrated Analyses of m6A Regulator-Based Signature on Its Clinical Application and Immunogenomic Landscape in Stomach Adenocarcinoma
por: Zhang, Lan, et al.
Publicado: (2022)

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer
por: Li, Zhaoxing, et al.
Publicado: (2021)

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma
por: Wang, Jianlin, et al.
Publicado: (2018)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Knockdown of CDCA5 suppresses malignant progression of breast cancer cells by regulating PDS5A
por: Wang, Yang, et al.
Publicado: (2022)

A novel 6-gene signature derived from tumor-infiltrating T cells and neutrophils predicts survival of bladder urothelial carcinoma
por: Zou, Xuan, et al.
Publicado: (2021)

A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors
por: Fang, Hui, et al.
Publicado: (2022)

CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker
por: Shen, Zhiqing, et al.
Publicado: (2018)

SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway
por: Luo, Zhenzhen, et al.
Publicado: (2021)

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
por: Li, Tianhao, et al.
Publicado: (2023)

The role of the CDCA gene family in ovarian cancer
por: Chen, Chongxiang, et al.
Publicado: (2020)

Prognostic value of CDCA3 in kidney renal papillary cell carcinoma
por: Li, Hao, et al.
Publicado: (2021)

CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Wang, Zhihuai, et al.
Publicado: (2021)

Bioinformatics analysis of the clinical relevance of CDCA gene family in prostate cancer
por: Gu, Peng, et al.
Publicado: (2022)

The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Jin, Xin, et al.
Publicado: (2022)

ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma
por: Zhang, Qiaoling, et al.
Publicado: (2022)

Clinical implication and immunological landscape analyses of ANLN in pan‐cancer: A new target for cancer research
por: Zhang, Lan, et al.
Publicado: (2022)

Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer
por: Lu, Mingjie, et al.
Publicado: (2017)

The Comprehensive Analysis Illustrates the Role of CDCA5 in Breast Cancer: An Effective Diagnosis and Prognosis Biomarker
por: Gao, Yang, et al.
Publicado: (2023)

Pan-cancer analysis identifies CDCA3 as a novel prognostic marker associated with immune infiltration in lung adenocarcinoma through bioinformatics analysis
por: Yang, Hao, et al.
Publicado: (2022)

Identification of CDCA8, DSN1 and BIRC5 in Regulating Cell Cycle and Apoptosis in Osteosarcoma Using Bioinformatics and Cell Biology
por: Li, Qinwen, et al.
Publicado: (2020)

Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner
por: Wang, Jiahui, et al.
Publicado: (2022)

TACC3 as an independent prognostic marker for solid tumors: a systematic review and meta-analysis
por: Wang, June, et al.
Publicado: (2017)

A panel of 13-miRNA signature as a potential biomarker for predicting survival in pancreatic cancer
por: Zhou, Xin, et al.
Publicado: (2016)

Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma
por: Xu, Jing, et al.
Publicado: (2019)

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer
por: Wan, Shun, et al.
Publicado: (2022)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2021)

CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation
por: Fu, Guanghou, et al.
Publicado: (2020)

High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer
por: Li, Siman, et al.
Publicado: (2020)

CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2017)

High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity
por: Wang, Yunhan, et al.
Publicado: (2023)

Comprehensive Analysis of Aerobic Exercise-Related Genes Identifies CDCA4 That Promotes the Progression of Osteosarcoma
por: Hao, Suyu, et al.
Publicado: (2021)

CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma
por: Li, Hongyi, et al.
Publicado: (2021)

Meta-Analysis of the Prognostic Value of Smad4 Immunohistochemistry in Various Cancers
por: Du, Yiping, et al.
Publicado: (2014)

KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2021)

Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer
por: Kariri, Yousif A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vh78vbj09tkhtb969e70ssvm3s